SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹67 Cr | ₹108 Cr | ₹94 Cr | ₹46 Cr | ₹20 Cr |
What is the latest Total Non-Current Liabilities ratio of SAKAR HEALTHCARE ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹67 Cr |
Mar2023 | ₹108 Cr |
Mar2022 | ₹94 Cr |
Mar2021 | ₹46 Cr |
Mar2020 | ₹20 Cr |
How is Total Non-Current Liabilities of SAKAR HEALTHCARE Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹67 Cr | -38.00 | |
Mar2023 | ₹108 Cr | 15.99 | |
Mar2022 | ₹94 Cr | 103.03 | |
Mar2021 | ₹46 Cr | 135.46 | |
Mar2020 | ₹20 Cr | - |
Compare Total Non-Current Liabilities of peers of SAKAR HEALTHCARE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAKAR HEALTHCARE | ₹817.6 Cr | 4.2% | 1.4% | 13.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,991.0 Cr | -0.1% | 1.3% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,720.0 Cr | -1.7% | 0.5% | 47.2% | Stock Analytics | |
CIPLA | ₹120,133.0 Cr | 0.4% | -1.5% | -1.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,994.0 Cr | -0.2% | 9% | 13.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,562.0 Cr | 0.5% | -5.7% | -9.1% | Stock Analytics |
SAKAR HEALTHCARE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAKAR HEALTHCARE | 4.2% |
1.4% |
13.6% |
SENSEX | -0.1% |
0.2% |
2.1% |
You may also like the below Video Courses